Shar Jackson discusses the importance of preventative health screenings with Dr. Steven Rabin

January 8, 2018 Providence Health Team

Share this Article
Facebook
Twitter
Email
LinkedIn

Actress and mother of four, Shar Jackson, is a fervent advocate of health screenings for both men and women. Jackson nearly lost her mother to an illness she believes could have been prevented or caught early through testing, which inspired her to speak out about the importance of regular health screenings. Then, her uncle’s pancreatic cancer was diagnosed early due to preventative care, which ultimately saved his life. Watch what she and Dr. Steven Rabin discuss the importance of health screenings.

7 Surprising Health Problems Connected to Being Overweight

Health problems connected to being overweight

5 Surprising Reasons You Can't Donate Blood

Here are five reasons you may not be allowed to give blood. Only one in 30 people regularly gives...

Other content in this Stream

Can photo-immunotherapy improve outcomes in advanced solid tumors?

Shar Jackson discusses the importance of preventative health screenings with Dr. Steven Rabin

Previous Article

Next Article

Other content in this Stream

Providence Cancer Institute to offer a new phase I/II study of a first-in-class photoimmunotherapy for solid tumors that overexpress the epidermal growth factor receptor protein.

Peter Chung, an energetic 42-year-old, never imagined he would be dealing with a cancer diagnosis at such a young age.

Providence's Dr. Abbass uses robotics to perform surgeries like the Whipple procedure to help pancreatic cancer patients get back to life. Learn more.

Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, will join oncology professionals around the world for the 2021 ASCO Annual Virtual Conference.

New technology and neurosurgery expertise available 24/7

Immunology leader Dr. Walter Urba talks about his healthcare journey and how Providence is defining the future of personalized care.

Providence Cancer Institute to offer phase II clinical trial of neoadjuvant chemotherapy plus immunotherapy for patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Providence's Amy Compton-Phillips breaks down how genomics is helping to chart the future of personalized care. Learn more.

Low-dose CT screening offers reassurance to people at high risk for the disease.

Learn how Providence’s partnership with City of Hope helped a patient reduce his commute and spend more time doing what he loves.

A phase II, investigator-initiated clinical trial at Providence Cancer Institute aims to improve survival for patients with triple-negative breast cancer. The trial is available only at Providence.

With funding from the Kuni Foundation, the Center for Outcomes Research & Education (CORE) will investigate disparities in breast cancer screening rates.

Anton J. Bilchik, MD, PhD at Providence Saint John’s explains why timely colorectal cancer screening is important.

When a woman discovers she has ovarian, uterine or another gynecologic cancer, she needs every source of help to heal. Providence Holy Cross Medical Center and City of Hope offer comprehensive care.

A dietitian and a physical therapist share their experiences in helping patients finish cancer. Learn more.

Learn about a potential immune benefit for infants from lactating mothers who have received a COVID-19 vaccine.

New clinical trial at Providence Cancer Institute combining targeted therapy with checkpoint immunotherapy for patients with metastatic thyroid cancer.

Michael Kelley Endowed Chair for Cancer Research awarded to Providence Cancer Institute radiation oncologist, Dr. Marka Crittenden.

Attendees will have an opportunity to connect with experts in the immunotherapy field at the live virtual event held on Thursday, April 8, 2021.

Providence and MSFT team to combat the flu. Learn more.